Vetsys Pharmaceutical
Vetsys Pharmaceutical
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) has cemented its position as a cornerstone of the animal pharmaceutical industry in China. With a robust registered capital of 30 million RMB, our presence is not merely local; it is a global beacon of quality and reliability. Our state-of-the-art facility is equipped with specialized workshops designed to produce an extensive portfolio, including water-soluble powders, premixes, injections, oral solutions, and innovative herbal drug extracts.
Operating under strict Good Manufacturing Practices (GMP), Vetsys ensures that every gram of soluble powder meets international safety and efficacy standards. By 2015, our domestic sales exceeded USD 20 million, reflecting the deep trust that veterinarians and farmers place in our products. As a premier exporter, we are now bringing this legacy of excellence to the global stage.
The industrial livestock sector is shifting toward water-soluble treatments for rapid, mass-scale delivery of medicine, reducing labor costs significantly.
Increasing focus on "Green Pharmacy" and precision dosing is driving the demand for high-purity, bioavailable soluble powders.
Global buyers prioritize manufacturers with stable supply chains and verified GMP certifications to combat antimicrobial resistance (AMR).
Water-soluble technology ensures that active ingredients remain stable in various water qualities across the globe.
Industrial Significance: Soluble powders are the lifeblood of modern intensive farming. In regions like Southeast Asia, Latin America, and the Middle East, where poultry and swine production is booming, the ability to treat thousands of animals simultaneously through drinking systems is a game-changer. As a leading China Soluble Powders Factory, Vetsys addresses this need with superior solubility and pharmacological stability.
Vetsys distinguishes itself through a relentless pursuit of technological development. Our independent research institute houses five specialized laboratories, staffed by world-class scientists focused on molecular pharmacology and advanced formulation techniques. This research capability allows us to produce cutting-edge solutions for complex animal health challenges, such as respiratory infections and gut health management.
Our commitment to R&D ensures that our soluble powders, such as Tylosin Doxycycline and Amoxicillin, offer maximum absorption and minimal waste, directly contributing to the sustainability of the global animal protein industry.
Mold Injection
Welding
Assembly
Packaging
From raw material synthesis to final packaging, we control every step to ensure cost-efficiency and quality.
We provide comprehensive documentation and registration support for international markets, including GMP and ISO certifications.
Investing in green technologies to minimize environmental impact while promoting the well-being of livestock.
Buyers from Europe, Africa, and the Americas seek China Top Soluble Powders Factories for their ability to provide high-volume, high-quality products at competitive prices. Vetsys goes a step further by offering tailored localized application scenarios—whether it is Amoxicillin Soluble Powder for tilapia farming in Vietnam or Oxytetracycline for cattle in Brazil.
Vetsys believes that excellence in product quality is essential to long-term sustainability. Our Quality Management System (QMS) oversees every aspect of production. All products are manufactured under optimal conditions and undergo extensive quality control checks—from raw material purity tests to final solubility trials—before reaching the market.
Injection Molding
Blow Molding
Extrusion Molding
Processing
Drying
Final Assembly
At Vetsys, we are driven by our mission to improve animal health through continuous innovation, world-class quality, and sustainable practices. Our future strategy includes strategic global partnerships, research collaborations, and expanding our manufacturing capabilities to meet the increasing demand for safe and effective animal drugs worldwide. We remain committed to creating value for our customers, employees, and society as we continue to shape the future of animal healthcare.
